Riordan, Lewis & Haden’s sale of Avella fetches about $325 mln


Riordan, Lewis & Haden, Avella Specialty Pharmacy, UnitedHealth Group, Drugs, medicine, pharmacy, private equity, merger, M&A,
Photo courtesy 4X-image/ iStock/Getty Images

To view this content you must sign in:

Not yet registered? Join today to access PE Hub industry insights and updates.